Overview


According to FutureWise analysis the market for Nebulizer Devices in 2023 is US$ 1.2 billion, and is expected to reach US$ 1.95 billion by 2031 at a CAGR of 6.22%.

The nebulizer is a device that is used to treat respiratory diseases and disorders include asthma, cystic fibrosis, and COPD. A nebulizer is a device that turns liquid medicine into a fine mist that may be inhaled through a mouthpiece or a face mask. The nebulizer turns liquids and solutions into tiny aerosol droplets that are inhaled through the mouthpiece. They are available in two sizes: a small version that can be carried and a larger version that sits on a table and plugs into a wall. The nebulization technique is commonly used to treat respiratory conditions like asthma, cystic fibrosis, and COPD. A number of devices are used for nebulization. The most frequently used devices are rechargeable and powered by electricity. The global Nebulizer devices Market is being driven by an increase in the prevalence of respiratory disorders along with an ageing population. Because of the significant economic burden associated with extended hospital stays, particularly for the treatment of chronic diseases, there is a growing desire for treatment in home care settings. Portable and hand-held nebulizers are perfect for long-term treatment of respiratory disorders like COPD and asthma in home care settings, thanks to their ease of use and ability to produce good outcomes, which is projected to fuel market expansion. In addition, the elderly prefer treatment in their own homes rather than in hospitals. Self-diagnosis and medication devices, such as nebulizers, are becoming more popular as a result of technological improvements in the healthcare industry, which is driving market expansion. Aside from that, rising pollution levels, which have been linked to an increase in the adoption of private vehicles and the expansion of industries, are contributing to the product's global demand.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Nebulizer Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Nebulizer Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Agilent Technologies, Inc.
  • Allied Healthcare Products, Inc.
  • CareFusion Corporation (sub. Becton, Dickinson and Company)
  • Covidien plc. (sub. Medtronic)
  • GE Healthcare
  • GF Health Products Inc.
  • Omron Healthcare, Inc.
  • PARI GmbH.
  • Koninklijke Philips N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Compressed Jet Nebulizer
    • Breath Actuated Pneumatic Nebulizer
    • Vented Actuated Pneumatic Nebulizer
  • Ultrasound Nebulizer
  • Mesh Nebulizer

By Application

  • COPD
  • Cystic Fibrosis
  • Asthma
  • Others

By End User

  • Homecare Settings
  • Out Patient Settings
  • Others
    • Hospitals
    • Clinics
    • Long Term Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Nebulizer Devices Market By Product Type, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Nebulizer Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Nebulizer Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Nebulizer Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Nebulizer Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Compressed Jet Nebulizer
         1.1. Breath Actuated Pneumatic Nebulizer
         1.2. Vented Actuated Pneumatic Nebulizer
        2. Ultrasound Nebulizer
        3. Mesh Nebulizer

  • 8.   Nebulizer Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. COPD
        2. Cystic Fibrosis
        3. Asthma
        4. Others

  • 9.   Nebulizer Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Homecare Settings
        2. Out Patient Settings
        3. Others
         3.1. Hospitals
         3.2. Clinics
         3.3. Long Term Centers

  • 10.   North America Nebulizer Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Nebulizer Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Nebulizer Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Nebulizer Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Agilent Technologies, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Allied Healthcare Products, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CareFusion Corporation (sub. Becton, Dickinson and Company)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Covidien plc. (sub. Medtronic)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GE Healthcare
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. GF Health Products Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Omron Healthcare, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PARI GmbH.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Koninklijke Philips N.V.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients